Our finding of lower TGF-β levels in PBMC culture supernatants of MS patients is relevant and provides a plausible mechanism for the upregulation of GM-CSF across immune cell lineages along with elevated pro-inflammatory cytokines in MS. The gene discussed is CSF2; the disease is myeloid sarcoma.